Litcius/Paper detail

Similar risk of hepatocellular carcinoma during long-term entecavir or tenofovir therapy in Caucasian patients with chronic hepatitis B

George Papatheodoridis, George Ν. Dalekos, Ramazan Idılman, Vana Sypsa, Florian van Bömmel, Marı́a Buti, José Luís Calleja, John Goulis, Spilios Manolakopoulos, Alessandro Loglio, Μargarita Papatheodoridi, Nikolaos Gatselis, Rhea Veelken, Marta López-Gómez, Bettina E. Hansen, Savvoula Savvidou, Anastasia Κourikou, Jiannis Vlachogiannakos, Kostas Galanis, Cihan Yurdaydın, Rafael Esteban, Harry L.A. Janssen, Thomas Berg, Pietro Lampertico

2020Journal of Hepatology88 citationsDOI

Topics & Concepts

MedicineHepatocellular carcinomaEntecavirCirrhosisInternal medicineGastroenterologyHazard ratioIncidence (geometry)HBsAgHepatitis BCumulative incidenceProportional hazards modelLiver transplantationCohortHepatitis B virusTransplantationImmunologyLamivudineConfidence intervalVirusOpticsPhysicsHepatitis B Virus StudiesHepatitis C virus researchHepatocellular Carcinoma Treatment and Prognosis
Similar risk of hepatocellular carcinoma during long-term entecavir or tenofovir therapy in Caucasian patients with chronic hepatitis B | Litcius